Eli Lilly licenses Peptron’s SmartDepot by October 7?
Open1as of
Market pricing makes Eli Lilly licenses Peptron’s SmartDepot by October 7? the favorite at 13%, as of .
What are the odds right now?
Each outcome shows its current market price — the market-implied probability it happens. Click an outcome for its full market page.
What moved the odds?
No directional matched news signals are available across this event yet.
What is this event about?
This market will resolve to “Yes” if Eli Lilly signs a commercial licensing agreement, technology transfer agreement, or equivalent binding agreement with Peptron that grants Eli Lilly commercial rights to Peptron’s SmartDepot technology by the specified date, 11:59 PM Korea Standard Time. Otherwise, this market will resolve to “No”.
Only commercial licensing agreements, technology transfer agreements, or equivalent binding agreements that grant Eli Lilly direct commercial rights to develop, manufacture, sell, or otherwise commercialize Peptron’s SmartDepot technology will qualify.
Co-development agreements will not qualify. Extensions of the existing Technology Evaluation Agreement or other agreements which are non-binding or do not grant Eli Lilly direct commercial rights to SmartDepot will not qualify.
The primary resolution source for this market will be official information from Eli Lilly and Peptron; however, a consensus of credible reporting may also be used.